Inventurus Knowledge Solutions Share News - Latest Updates, Live News & More

More news about Inventurus Knowledge Solutions

IKS subsidiary sells Abridge AI stake for USD 10.00M

Inventurus Knowledge Solutions Limited disclosed a stock purchase agreement wherein its subsidiary, Inventurus Knowledge Solutions Inc, sold 54,055 Series A-1 Preferred Shares in Abridge AI Inc. The shares were sold to Alpha Square Group Fund IV, LP for USD 10,000,175. The deal, dated August 05, 2026, is a non-related party transaction aimed at partial divestment and monetization of assets.

06Aug 26

Inventurus Knowledge Solutions Q1 Results: Net Profit Rises to ₹1.94B YoY

Inventurus Knowledge Solutions delivered year-on-year growth across all key financial parameters in Q1, with consolidated net profit rising to ₹1.94B from ₹1.52B. Revenue increased to ₹8.94B from ₹7.4B, and EBITDA grew to ₹2.95B from ₹2.38B over the same period. The EBITDA margin expanded to 33.01% from 32.12% YoY, reflecting improved operational efficiency during the quarter.

06Aug 26

IKS Health names Clarence King II as new Chairman after Berjis Desai retires

IKS Health's Board approved Berjis Desai's retirement as Chairman due to his new government role, appointing Clarence King II as successor effective from the AGM on September 21, 2026. This governance update accompanies Q1FY27 results showing 27.8% PAT growth and recent strategic acquisitions.

05Aug 26

Inventurus Knowledge Solutions Q1 Results: Earnings call scheduled for Aug 6

Inventurus Knowledge Solutions Limited has scheduled its Q1 FY27 earnings conference call for August 6, 2026, at 8:30 AM IST. The disclosure complies with SEBI LODR Regulation 30. Dial-in details for domestic and international participants have been provided, with Saransh Mundra listed as the point of contact for investor relations.

04Aug 26

IKS Health syndicates TruBridge acquisition financing with global banks

Inventurus Knowledge Solutions Limited has finalized a syndication agreement for its TruBridge, Inc. acquisition financing. Dated August 3, 2026, the deal involves Citigroup, Deutsche Bank, and JP Morgan as arrangers, with new lenders including HDFC Bank, ICICI Bank, and SBI joining the facility. The Company's obligations extend to these new lenders, securing the financial framework for the transaction previously announced in April and July 2026.

29Jul 26

Inventurus Knowledge Solutions sets up US subsidiary for value-based care

Inventurus Knowledge Solutions Limited incorporates Value Partners Collective ACO, LLC in the US to apply for the CMS LEAD program. The $0-capitalized subsidiary aims to manage value-based healthcare costs but will dissolve if not selected by CMS, posing no immediate financial impact.

14Jul 26

IKS Health subsidiary invests USD 2.84M in WWMG MSO

Inventurus Knowledge Solutions Ltd's subsidiary completed a USD 2.84M investment in IKS WWMG MSO LLC, increasing its ownership to 51.88%. This follows the earlier USD 557M acquisition of TruBridge Inc, supported by USD 635M in debt facilities used to refinance prior loans. The combined entity targets a USD 260 billion market, leveraging AI to serve over 2,000 healthcare organizations.

01Jul 26

IKS Health delivers $12 million annual cash impact for Axia Women's Health

Inventurus Knowledge Solutions Limited (IKS Health) achieved $12 million in annual cash impact for Axia Women's Health by scaling its coding partnership to cover 100% of volume. The initiative reduced denial rates by over a third, boosted monthly collections to $14.3 million, and improved coding accuracy above 96%.

01Jul 26

Inventurus Knowledge Solutions invests $15M in IKS WWMG MSO

Inventurus Knowledge Solutions approved an additional investment of up to $15 million in IKS WWMG MSO LLC, increasing its stake to 63.49%. The total investment is expected to reach $32 million by 2029, funding physician hiring and VBC expansion. Operational metrics show improved efficiency with reduced DSO and increased visit counts.

02Jun 26

Inventurus Knowledge Solutions to host investor meet on June 8

Inventurus Knowledge Solutions Limited has announced an Analyst and Institutional Investor Meet scheduled for June 08, 2026, at the Grand Hyatt in Mumbai. The meeting, part of the ICICI Securities India Investor Conference, will run from 09:00 AM IST to 05:00 PM IST. The company confirmed that no unpublished price sensitive information will be disclosed during the event.

31May 26

Inventurus Knowledge Solutions shareholders approve subsidiary resolutions

Inventurus Knowledge Solutions Limited shareholders have approved special resolutions authorizing the pledge or disposal of shares and assets of material subsidiaries and the provision of guarantees for its wholly-owned subsidiary, Inventurus Knowledge Solutions, Inc. The remote e-voting process concluded on May 29, 2026, with over 99.66% of votes cast in favour. The resolutions were passed under Regulations 24(5) and 24(6) of the SEBI LODR Regulations, 2015.

26May 26

Inventurus Knowledge Solutions to host investor meet on June 1

Inventurus Knowledge Solutions announced an Analyst and Institutional Investor Meet scheduled for June 1, 2026, at the Grand Hyatt in Mumbai. The meeting, part of the Axis Capital Rising Stars Conference 2026, will involve multiple investors and will not disclose any unpublished price sensitive information.

19May 26

Inventurus FY26 PAT Jumps 48% as Q4 EBITDA Margin Expands to 35%

Inventurus Knowledge Solutions Limited reported strong FY26 results with PAT surging 48.4% to ₹7,216 mn and Q4 FY26 EBITDA margin expanding to 35.0%. The company published its audited financial results in Financial Express and Navshakti on May 15, 2026, per Regulation 47 of SEBI LODR. Strategic moves include the acquisition of Arai Solutions for ₹11 crores and the launch of the MyCareHub™ agentic AI platform.

15May 26

IKS Health Completes Arai Solutions Acquisition for INR 11 Crores to Boost AI Stack

Inventurus Knowledge Solutions Limited's IKS Health completed the acquisition of 100% stake in Arai Solutions Private Limited for INR 11,00,00,000 on May 14, 2026, one day after Board approval. The deal adds ARAI's biomedical knowledge graphs and explainable AI capabilities to IKS Health's four-layer healthcare AI stack, with Arai Solutions now a wholly-owned subsidiary. The acquisition targets acceleration in autonomous coding, clinical decisions, denial prevention, prior authorization reasoning, and precision medicine.

14May 26

Inventurus Knowledge Solutions Posts Q4 FY26 Call Recording

Inventurus Knowledge Solutions announced the availability of the audio recording for its Q4 FY 2025-26 earnings conference call held on May 14, 2026. The disclosure complies with SEBI LODR Regulations, and the recording is hosted on the company's website for investor access.

14May 26

Inventurus Knowledge Solutions Announces Change in Senior Management Personnel Classification

Inventurus Knowledge Solutions Limited disclosed on May 13, 2026, that Saransh Mundra will no longer be classified as Senior Management Personnel effective May 14, 2026, following a review of internal roles and responsibilities. The Board of Directors approved the change at its meeting held the same day. Mundra continues to remain part of the organisation with responsibility for investor relations. The disclosure was made under Regulation 30 of the SEBI LODR Regulations.

14May 26

Inventurus re-appoints KKC & Associates as Internal Auditor

Inventurus Knowledge Solutions Limited has re-appointed M/s KKC & Associates LLP as its Internal Auditor for the financial year 2026-27. The Board approved the appointment on May 13, 2026. KKC & Associates LLP is a chartered accountancy firm with over 350 professionals and offices in major cities.

06May 26

IKS Health Announces Strategic Multi-Year Partnership with Holyoke Medical Center to Reduce Administrative Burden

IKS Health, the healthcare arm of Inventurus Knowledge Solutions Limited, announced a strategic multi-year clinical and revenue optimization platform partnership with Holyoke Medical Center, a 219-bed independent, non-profit community hospital in Western Massachusetts, on May 5, 2026. The partnership aims to reduce clinical and administrative burden, lower operating costs, and unlock new revenue opportunities for the hospital, which employs over 1,800 staff and more than 375 physicians. The collaboration leverages IKS Health's Care Enablement platform, combining agentic AI workflows with human expertise to streamline clinical and financial operations. IKS Health, founded in 2006, is recognized by Black Book Research as the top provider of AI-driven RCM services and by Google Cloud with a DORA Award for augmenting human expertise with AI.

30Apr 26

Inventurus Knowledge Solutions Dispatches Postal Ballot Notice for SEBI Compliance and Subsidiary Guarantee Resolutions

Inventurus Knowledge Solutions Limited has dispatched its postal ballot notice on April 28, 2026, for two special resolutions requiring shareholder approval. The resolutions cover SEBI LODR compliance for material subsidiary transactions and guarantee provisions for its wholly owned subsidiary. E-voting is scheduled from April 30 to May 29, 2026, with results expected by June 2, 2026.

30Apr 26

Inventurus Knowledge Solutions Submits TruBridge Acquisition Conference Call Transcript

Inventurus Knowledge Solutions filed conference call transcript with exchanges regarding TruBridge acquisition, revealing comprehensive strategic rationale for USD 565 million deal targeting rural healthcare market. Management outlined integration timeline, financial projections, and growth opportunities while awaiting shareholder approval through postal ballot process.

29Apr 26

Inventurus Knowledge Solutions Grants 12,700 Employee Stock Options Under ESOP Plan 2022

Inventurus Knowledge Solutions Limited's Nomination and Remuneration Committee has approved the grant of 12,700 employee stock options under the IKS ESOP Plan 2022 at an exercise price of Rs. 1,505.20 per option. The options are convertible into equity shares with Re. 1 face value each and comply with SEBI regulations, with comprehensive provisions for vesting, exercise, and corporate actions.

15Apr 26

IKS Health Launches MyCareHub AI Platform at AMGA 2026 Conference, Reports Strong Performance Metrics

Inventurus Knowledge Solutions Limited announced IKS Health's launch of MyCareHub, an agentic AI platform for patient engagement, at the 2026 AMGA Annual Conference in Las Vegas. The Epic-integrated platform uses multi-agent behavioral algorithms and advanced technologies including behavioral modeling, decision intelligence, and personalized communication systems. Implementation at OrthoNY since 2025 shows strong performance with 4.7% increase in total patient collections, 9.4% rise in patient payments per visit, and 8.25% increase in net payments per visit year-over-year.

14Apr 26

IKS Health Clarifies TruBridge Acquisition Discussions Following Media Reports

Inventurus Knowledge Solutions Limited clarified to BSE that while its subsidiary participated in discussions for a potential TruBridge acquisition reported in media, no binding agreements have been executed. The discussions remain non-binding and subject to various contingencies including negotiations and approvals. The company emphasized its commitment to regulatory compliance and will disclose material developments as required under applicable regulations.

11Apr 26

Inventurus Knowledge Solutions Submits Quarterly Compliance Certificate for Q4FY26

Inventurus Knowledge Solutions Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE and NSE on April 10, 2026. The certificate, issued by Registrar MUFG Intime India Private Limited, confirms proper handling of dematerialisation processes for the quarter ended March 31, 2026, with all securities processed within prescribed timelines and regulatory requirements met.

08Apr 26

Inventurus Knowledge Solutions: IKS Health Launches Audit-Ready Autonomous Coding With Expert Human Support, Claiming Up To 95% Accuracy

Inventurus Knowledge Solutions, operating as IKS Health, has launched an advanced AI-driven autonomous coding engine that delivers up to 95% coding accuracy while addressing the 12% average claim denial rate in U.S. healthcare. The solution integrates with Epic Connection Hub and combines artificial intelligence with expert human review processes to analyze patient charts and suggest medical codes. The system provides comprehensive audit readiness with justification reports and operates as a vendor-agnostic solution compatible with various healthcare systems.

02Apr 26

Inventurus Knowledge Solutions Completes USD 40M Investment in Subsidiary IKS Inc

Inventurus Knowledge Solutions has successfully completed its comprehensive investment plan in wholly owned subsidiary IKS Inc, investing approximately USD 40 million across two tranches. The company acquired a total of 62,176 shares, with the final tranche of USD 20,990,505 for 32,635 shares completed in April 2026, demonstrating strategic commitment to strengthening subsidiary operations.

01Apr 26

IKS Health Announces Strategic Acquihire of AI Company ThinkDTM to Expand Patient Access Solutions

Inventurus Knowledge Solutions Limited announced the strategic acquihire of AI company ThinkDTM through its IKS Health subsidiary. ThinkDTM Founder Tij Bedi joins as Executive Vice President and General Manager, Patient Access and Innovation, bringing his AI expert team to expand patient access solutions including scheduling, registration, and insurance verification. The acquisition strengthens IKS Health's agentic AI capabilities in healthcare operations.

25Mar 26

IKS Health and Certilytics Expand Strategic Partnership for Agentic AI Healthcare Solutions

Inventurus Knowledge Solutions announced on March 24, 2026, that IKS Health has expanded its strategic partnership with Certilytics to bridge the payer-provider gap through agentic AI and human oversight. The collaboration integrates advanced AI platforms to manage healthcare tasks autonomously while maintaining human supervision, focusing on prior authorization transparency, member engagement, and consumer price transparency.

18Mar 26

IKS Health Secures Triple Win in Black Book's 2026 Healthcare Technology Awards

Inventurus Knowledge Solutions Limited's IKS Health division secured three top awards from Black Book Research for 2026, winning in AI-driven RCM for the second consecutive year, medical coding for the fourth year running, and clinical documentation and AI services for 13 straight years. The company ranked No. 1 in multiple performance indicators across all three categories, based on comprehensive surveys of over 1,000 healthcare industry respondents. Black Book Research projects significant market growth in these segments, with 35% to 55% of providers expecting increased spending in 2026.

14Mar 26

Inventurus Board Approves $40M Investment in IKS Inc with Detailed Structure

Inventurus Knowledge Solutions' board approved a $40 million additional investment in its wholly owned subsidiary IKS Inc during a March 13, 2026 meeting. The investment will be executed in tranches, starting with $20 million for 31,096 shares at $643.19 per share, with completion targeted by May 31, 2026. IKS Inc, a Delaware-incorporated healthcare technology company, reported revenue from operations of ₹6,941.11 million in FY 2024-25.

12Mar 26

Inventurus Knowledge Solutions Receives ₹17.44 Lakh Penalty from SEEPZ-SEZ Mumbai

Inventurus Knowledge Solutions Limited received a penalty of ₹17,44,894 from SEEPZ-SEZ Mumbai for improper classification of services under CPC codes during FY2015-16 to FY2018-19 while availing SEIS benefits. The company disclosed this on March 12, 2026, stating no impact on financial or operational activities.

05Mar 26

Inventurus Knowledge Solutions Grants 600,000 Employee Stock Options Under ESOP Plan 2022

Inventurus Knowledge Solutions Limited granted 600,000 employee stock options under its ESOP Plan 2022 on March 5, 2026, with an exercise price of Rs. 1,331.00 per option. Each option converts to one equity share with Re. 1 face value, and the exercise price matches the March 4, 2026 NSE closing price. The plan includes comprehensive provisions for various employment scenarios and corporate actions, with no lock-in restrictions on exercised shares.

24Feb 26

Inventurus Knowledge Solutions Grants 54,000 Employee Stock Options Under ESOP Plan

Inventurus Knowledge Solutions Limited granted 54,000 employee stock options under its IKS ESOP Plan on February 24, 2026, at an exercise price of Rs. 1,540.20 per option. The Nomination and Remuneration Committee approved the grant, which complies with SEBI regulations and allows conversion into equity shares with Re. 1 face value each. The company made required regulatory disclosures to BSE and NSE, with the plan administered through a Trust and including provisions for various employment scenarios and corporate actions.

06Feb 26

Archies Limited Schedules Board Meeting for February 11, 2026 to Review Q3FY26 Financial Results

Archies Limited has scheduled a board meeting for February 11, 2026 to review Q3FY26 unaudited financial results. The announcement follows SEBI regulations with information available on company and stock exchange websites. Concurrently, Inventurus Knowledge Solutions reported strong Q3FY25 performance with consolidated revenue of ₹8,149.50 million and profit of ₹1,833.28 million, while Astral Limited also published its quarterly results for the same period.

04Feb 26

Inventurus Knowledge Solutions Q3FY26: Revenue Grows 24% to ₹8.15B, EBITDA Surges 40%

Inventurus Knowledge Solutions delivered impressive Q3FY26 performance with 24% revenue growth to ₹8.15B and 40% EBITDA surge to ₹2.82B, driven by strategic partnerships with healthcare providers including StrideCare and VitalMD Group. The company filed its investor presentation with stock exchanges under regulatory requirements while receiving industry recognition including Best in KLAS Award for Virtual Scribing Services.

30Jan 26

Inventurus Knowledge Solutions Grants 122,000 Employee Stock Options Under ESOP Plan 2022

Inventurus Knowledge Solutions Limited granted 122,000 employee stock options under its ESOP Plan 2022 on January 30, 2026, with approval from the Nomination and Remuneration Committee. The options are priced at Rs. 1,537.10 per option, aligned with market price based on NSE closing rates from January 29, 2026. Each option converts to one equity share of Re. 1 face value, and the plan operates in full compliance with SEBI regulations through a Trust structure.

27Jan 26

Inventurus Knowledge Solutions Schedules Q3 FY 2025-26 Earnings Call for February 5, 2026

Inventurus Knowledge Solutions Limited has scheduled its Q3 FY 2025-26 earnings conference call for February 5, 2026, at 8:30 AM IST. The company filed the regulatory disclosure on January 27, 2026, providing multiple access options including universal dial-in numbers and international toll-free numbers for USA, UK, Singapore, and Hong Kong. The call will discuss quarterly results with comprehensive participation arrangements for investors and analysts.

22Jan 26

Inventurus Knowledge Solutions Grants 525,000 Employee Stock Options Under ESOP Plan 2022

Inventurus Knowledge Solutions Limited granted 525,000 employee stock options under its ESOP Plan 2022 on January 22, 2026. The grant includes 420,000 options at ₹1,664.30 and 105,000 options at ₹320.00, both convertible to equity shares with ₹1 face value. The options have different exercise terms and comply with SEBI regulations.

07Jan 26

Inventurus Knowledge Solutions Schedules Analyst and Institutional Investor Meet for January 20, 2026

Inventurus Knowledge Solutions Limited has scheduled an analyst and institutional investor meet for January 20, 2026, from 2:00 PM to 6:30 PM IST at IKS Health Auditorium in Navi Mumbai. The meeting will be conducted in hybrid format with both in-person and virtual participation options. The company has confirmed compliance with SEBI regulations and stated that no unpublished price sensitive information will be shared during the event.

22Dec 25

Avendus Initiates Buy Rating on Inventurus Knowledge Solutions with Target Price of ₹2,020

Avendus Securities has started coverage on Inventurus Knowledge Solutions with a Buy rating and a target price of ₹2,020.00. This initiation suggests significant upside potential for the IT software company's stock, reflecting the brokerage's positive outlook on the company's prospects.

25Nov 25

Inventurus Knowledge Solutions Expands with New 1000-Seat Facility in Coimbatore

Inventurus Knowledge Solutions has opened a new 1000-seat office facility in Coimbatore to support its expansion into the US healthcare market. This strategic move is expected to create numerous job opportunities for local graduates and professionals across various roles. The expansion aims to enhance the company's service offerings, improve response times to US clients, and develop specialized solutions for the healthcare sector.

06Nov 25

IKS Health Reports Robust Q2 FY26 Performance with 22% Revenue Growth and 35% EBITDA Margins

Inventurus Knowledge Solutions Limited (IKS Health) reported impressive Q2 FY26 results. Revenue increased 22% YoY to ₹781.00 crores, EBITDA grew 43% to ₹272.00 crores, and PAT rose 60% to ₹181.00 crores. The company's EBITDA margin reached 35%, reflecting operational efficiency. IKS Health secured new clients, including AdventHealth and Revere Health, while accelerating its AI-native platform transformation. The company is focusing on about 50 customers with potential for $50 million each in Annual Contract Value over the next five years.

31Oct 25

Inventurus Knowledge Solutions Announces Senior Management Reshuffle

Inventurus Knowledge Solutions Limited (IKS) has announced a change in its Senior Management Personnel. Mr. Sameer Arora will be reassigned to a new role within the company, effective from the close of business hours on October 30, 2025. This change will result in Mr. Arora no longer being classified as Senior Management Personnel under the Companies Act, 2013 and SEBI LODR Regulations. The company has reported strong financial results for Q2 FY26, with revenue growth of 22% YoY to ₹7,811 million and PAT growth of 60% YoY to ₹1,807 million. IKS has also made recent strategic developments in AI and cloud technologies.

30Oct 25

Inventurus Knowledge Solutions Reports Strong Q2 FY26 Growth with 22% Revenue Surge and 60% PAT Increase

Inventurus Knowledge Solutions Limited announced robust Q2 FY26 results, with revenue up 22% to ₹7,811.00 million, EBITDA increasing 43% to ₹2,718.00 million, and PAT surging 60% to ₹1,807.00 million year-over-year. The company launched its Agentic AI platform on Google Cloud, received industry recognition, and expanded partnerships with healthcare providers. IKS Health aims to maintain balanced growth while investing in AI and technology innovations.

30Oct 25

Inventurus Knowledge Solutions Reports Strong Q2 Growth with 60% Jump in Net Profit

Inventurus Knowledge Solutions Limited (NSE: IKS) announced impressive Q2 financial results. Revenue increased by 21% year-over-year to INR 7,810.00 million. EBITDA surged 43% to INR 2,710.00 million, with margin improvement from 29.39% to 34.70%. Profit After Tax (PAT) saw a significant 60% increase, reaching INR 1,810.00 million. The company's performance is attributed to growing demand for its healthcare technology services, particularly its Care Enablement Platform, and strategic use of AI.

18Oct 25

Inventurus Knowledge Solutions Issues USD 77 Million Corporate Guarantee for Subsidiary's Loan Refinancing

Inventurus Knowledge Solutions Limited (IKS) has provided a new corporate guarantee of up to $77 million for its wholly-owned subsidiary, IKS Inc, to JPMorgan Chase Bank. This guarantee is part of IKS Inc's refinancing of its existing term loan, replacing a $146 million loan with a new $70 million facility. The new guarantee supersedes a previous $160.60 million guarantee. IKS states there's no immediate impact on its financial position, but it represents a contingent liability. The company has informed stock exchanges in compliance with SEBI regulations.

16Oct 25

IKS Health Unveils AI Platform on Google Cloud and Invests $10 Million in US Subsidiary

Inventurus Knowledge Solutions has introduced a generative AI platform using Google Cloud technologies to automate healthcare administration tasks. The platform can handle up to 80% of routine tasks, potentially reducing clinician burnout. Additionally, the company has invested $10,001,605 in its US subsidiary, Inventurus Knowledge Solutions Inc., acquiring 15,550 equity shares at $643.19 per share for working capital purposes.

22Sept 25

Inventurus Knowledge Solutions Unaffected by New H-1B Visa Fee, Reaffirms Business Model Strength

Inventurus Knowledge Solutions (IKS) announced that the new $100,000 fee for H-1B visa applications will not affect its business operations or financial projections. The company's business model, built on proprietary technology, an India-based skilled workforce, and local U.S. hiring, does not rely on H-1B visa holders. IKS reassured stakeholders that the visa fee changes would not impact client services, operational continuity, or growth objectives. The company remains committed to driving value through its Care Enablement Platform, supporting U.S. health systems with data-driven solutions and expertise.

05Sept 25

Inventurus Knowledge Solutions Appoints New Chief Human Resources Officer, Reshuffles Leadership

Inventurus Knowledge Solutions Limited (IKS) has announced key changes to its senior management. Manisha Kadagathur, with over 25 years of experience, joins as the new Chief Human Resources Officer (CHRO). Abhay Srivastava transitions to Head of Leadership Effectiveness, no longer part of Senior Management Personnel. These changes are effective from September 5, 2025.

02Aug 25

Inventurus Subsidiary Fined INR 1.5 Crore for Service Export Scheme Misclassification

Aquity Solutions India, a step-down subsidiary of Inventurus Knowledge Solutions Limited, has been penalized INR 1.5 crore by the Interim Settlement Board-III under the Ministry of Finance. The fine is due to misclassification of services under different CPC codes from 2015-16 to 2018-19 for availing Service Exports from India Scheme (SEIS) benefits. The company states there is no financial impact on Inventurus Knowledge Solutions Limited due to this order.

01Aug 25

Inventurus Knowledge Solutions Reports Strong Q1 FY26 Results, Announces Major Board Restructuring

Inventurus Knowledge Solutions posted robust Q1 FY26 results with 15.6% YoY revenue growth to ₹7,400.95 crore and 58.7% YoY PAT increase to ₹1,515.39 crore. The company expanded partnerships with healthcare providers and announced significant board changes, including founder Sachin Gupta transitioning to a non-executive role and becoming Global CEO of the US subsidiary. CFO Nithya Balasubramanian was appointed as Whole-time Director, and Dr. Garheng Albert Kong joined as an Independent Director.

01Aug 25

Inventurus Knowledge Solutions Reports Robust Q1 FY26 Results with 59% Surge in Net Profit

Inventurus Knowledge Solutions (NSE: IKS) announced robust Q1 FY26 financial results. Net profit surged 59% year-on-year to 1.52 billion rupees, while revenue grew 16% to 7.4 billion rupees. EBITDA margin improved to 32.1% from 27.3% in Q1 FY25. The company reported new partnerships and expansions, including collaborations with Mission Community Hospital and Bicycle Health. Key management changes include Sachin K. Gupta's designation as Global CEO of the US subsidiary, Nithya Balasubramanian's appointment as Additional Director, and Dr. Garheng Albert Kong joining as an Independent Director.

01Jul 25

Inventurus Knowledge Solutions Makes Strategic $17 Million Investment in U.S. Healthcare MSO

Inventurus Knowledge Solutions, an Indian company, is acquiring a 48.02% stake in a new U.S. healthcare Managed Service Organization (MSO) for $17 million (approximately ₹145 crore). This strategic move marks the company's entry into the U.S. healthcare market, potentially opening new revenue streams and growth opportunities in one of the world's largest healthcare sectors. The investment in an MSO, which typically provides administrative and management services to healthcare providers, aligns with the growing trend of outsourced healthcare management services in the United States.

19Jun 25

IKS Health: Block Deal Worth ₹400+ Crore Expected as Lock-in Period Ends

Inventurus Knowledge Solutions Ltd. (IKS Health) expects a block deal of about 1.5% of its equity on June 19, following a six-month lock-in period expiry. Multiple individual investors are likely to sell at a floor price of ₹1,650.00 per share, a 2.6% discount to the previous close. The deal, valued at over ₹400.00 crore, may attract buyers seeking a stake at a lower price point.

16May 25

Inventurus Knowledge Solutions Ltd: Q4 Revenue Soars 17%, EBITDA Up 68%

Inventurus Knowledge Solutions announced impressive Q4 results with a 133% year-over-year increase in net profit to ₹147.80 crore. Revenue grew by 17% to ₹724.00 crore, while EBITDA rose 68% to ₹226.20 crore. The company secured five major client wins, including three platform deals. For the full fiscal year, revenue reached ₹2,664.00 crore, marking a 47% growth compared to the previous year.

15May 25

Inventurus Knowledge Solutions Reports Robust Q4 Performance with Soaring EBITDA and Profit

Inventurus Knowledge Solutions has released its Q4 financial results, showing significant improvements across key metrics. Revenue increased by 16.77% to ₹7.24 billion. EBITDA grew by 79.37% to ₹2.26 billion, with the EBITDA margin expanding to 31.24%. Net profit surged by 132.82% to ₹1.48 billion. The results demonstrate the company's robust growth and enhanced profitability compared to the same period last year.

17Mar 25

Inventurus Knowledge Solutions Stock Dips 10% as Lock-in Period Expires

Inventurus Knowledge Solutions, backed by the Jhunjhunwala family, saw its stock price drop 10% to ₹1,497 on March 17, 2023, hitting a post-listing low of ₹1,440. The decline coincided with the end of a three-month shareholder lock-in period, making 42 lakh shares (2% of equity) available for trading. Despite the drop, the stock maintains a 24% premium over its IPO price of ₹1,331.